Cargando…

Pathological Mechanism and Targeted Drugs of COPD

Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis, emphysema, and small airway obstruction. Incompletely reversible airflow limitation, inflammation, excessive mucus secretion and bronchial mucosal epithelial lesions are the main pathological basis of the disease. The prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Peng, Li, Rui, Piao, Tie Hua, Wang, Chun Lan, Wu, Xiao Lu, Cai, Hong Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288175/ https://www.ncbi.nlm.nih.gov/pubmed/35855746 http://dx.doi.org/10.2147/COPD.S366126

Ejemplares similares

Progress in the mechanism and targeted drug therapy for COPD
por: Wang, Cuixue, et al.
Publicado: (2020)

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression
por: Peng, Guo-jiang, et al.
Publicado: (2015)

Pathological mechanism and targeted drugs of ulcerative colitis: A review
por: Guo, Meitong, et al.
Publicado: (2023)

Identifying targets for COPD treatment through gene expression analyses
por: Chen, Zhi-Hua, et al.
Publicado: (2008)

Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review
por: Xiao, Ying, et al.
Publicado: (2020)

Current Development of Nano-Drug Delivery to Target Macrophages
por: Cai, Donglin, et al.
Publicado: (2022)

Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis
por: Bateman, Georgia, et al.
Publicado: (2023)

Apoptotic mechanisms in the pathogenesis of COPD
por: Plataki, Maria, et al.
Publicado: (2006)

Targeting IL-5 in COPD
por: Narendra, Dharani K, et al.
Publicado: (2019)

Penehyclidine hydrochloride: a potential drug for treating COPD by attenuating Toll-like receptors
por: Xiao, Hong-Tao, et al.
Publicado: (2012)

Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
por: Tie, Yan, et al.
Publicado: (2022)

Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap
por: Zhang, Xiaoli, et al.
Publicado: (2018)

The pathology of small airways disease in COPD: historical aspects and future directions
por: Higham, Andrew, et al.
Publicado: (2019)

Role of the Arylhydrocarbon Receptor (AhR) in the Pathology of Asthma and COPD
por: Chiba, Takahito, et al.
Publicado: (2012)

Considerations for and Mechanisms of Adjunct Therapy in COPD
por: Mandru, Rachana, et al.
Publicado: (2021)

Targeting HDAC Complexes in Asthma and COPD
por: Zwinderman, Martijn R. H., et al.
Publicado: (2019)

Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain
por: Bista, Pawan, et al.
Publicado: (2019)

Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma
por: Guo, Xu, et al.
Publicado: (2022)

Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles
por: Hou, Yun-jing, et al.
Publicado: (2020)

Pathological transition as the arising mechanism for drug resistance in lung cancer
por: Chen, Yueqing, et al.
Publicado: (2019)

A review of nebulized drug delivery in COPD
por: Tashkin, Donald P
Publicado: (2016)

Role of Epigenetic Modifications in Pathology of COPD
por: Adcock, Ian Michael
Publicado: (2017)

Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL
por: Zhang, Jing, et al.
Publicado: (2023)

Novel aspects of pathogenesis and regeneration mechanisms in COPD
por: Bagdonas, Edvardas, et al.
Publicado: (2015)

Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer
por: Forder, Aisling, et al.
Publicado: (2023)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets
por: Lu, Jingli, et al.
Publicado: (2020)

Identification of Novel Therapeutic Targets in COPD
por: Mortaz, Esmaeil, et al.
Publicado: (2011)

Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target
por: Hughes, Michael J., et al.
Publicado: (2020)

Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?
por: Park, Sangmi S., et al.
Publicado: (2022)

Impaired Skeletal Muscle in Patients with Stable Chronic Obstructive Pulmonary Disease (COPD) Compared with Non-COPD Patients
por: Wu, Zhen-Yun, et al.
Publicado: (2023)

Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
por: Wu, Jiajia, et al.
Publicado: (2022)

Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
por: Lu, Da-Yong, et al.
Publicado: (2012)

Stimuli-responsive polymeric micelles for drug delivery and cancer therapy
por: Zhou, Qing, et al.
Publicado: (2018)

Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer
por: Putila, Joseph, et al.
Publicado: (2014)

“Teaching old dogs new tricks”: targeting neural extracellular matrix for normal and pathological aging-related cognitive decline
por: Richard, Adam D., et al.
Publicado: (2019)

Research on the Association Between Periodontitis and COPD
por: Xiong, Kaixin, et al.
Publicado: (2023)

Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms
por: McGuinness, Adam John Anthony, et al.
Publicado: (2017)

Biological targets for therapeutic interventions in COPD: clinical potential
por: Pelaia, Girolamo, et al.
Publicado: (2006)

The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions
por: Millares, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bbv76u4vbnb86fkddg5d88m5b3